CDH2 and gastric cancer: Knockdown of FGL1 could significantly increase the E-cadherin level of tumor cells and reduce the expression levels of vimentin and N-cadherin in tumor tissues, suggesting that FGL1 could promote the EMT process of gastric cancer (30).